HomeBusiness & MoneyCogent Biosciences down after market close on insider sales

Cogent Biosciences down after market close on insider sales


Bluberries

  • Shares of Cogent Biosciences (COGT) are down ~5% in after-hours trading Tuesday following the disclosure that several insiders recently made significant sales.
  • The company’s CFO, chief medical officer, chief science officer, and chief legal officer all disclosed sales in SEC filings.

Follow us on Google for the latest stock news



Source link

RELATED ARTICLES

Most Popular

Recent Comments